RESEARCH REPORT: Evaluation of a transdermal buprenorphine formulation in opioid detoxification

Buprenorphine is marketed in a sublingual formulation for treatment of opioid dependence. A transdermal formulation has been developed that may provide extended relief from opioid withdrawal, reduce required clinic visits and improve adherence, while having less potential for diversion and abuse. Th...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Addiction (Abingdon, England) England), 2007-10, Vol.102 (10), p.1648
Hauptverfasser:	Lanier, Ryan K, Umbricht, Annie, Harrison, Joseph A, Nuwayser, Elie S, Bigelow, George E
Format:	Artikel
Sprache:	eng
Schlagworte:	Addictions Clinical trials Narcotics Prescription drugs Substance abuse treatment Transdermal medication
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!